Unbound MEDLINE

Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. [Clin Infect Dis] Journal article

 
TitleAnaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy.
Author(s)Wareham DW, Wilks M, Ahmed D, Brazier JS, Millar M 
InstitutionDepartment of Microbiology, Barts & The London NHS Trust, London, United Kingdom. wareham@qmul.ac.uk
SourceClin Infect Dis 2005 Apr 1; 40(7):e67-8.
AbstractWe describe the first reported case of anaerobic sepsis due to Bacteroides fragilis with simultaneous resistance to metronidazole, beta-lactams, beta lactam/beta-lactamase inhibitors, carbapenems, macrolides, and tetracyclines. Microbiological cure and clinical improvement was achieved with linezolid therapy, an agent that may be useful for the treatment of multidrug-resistant anaerobic infections.
Languageeng
Pub Type(s)Journal Article
PubMed ID15824978
  
Advertise on this site.